High-quality development of subnational cancer prevention and control: investigation and experiences_West China Medical Journal

Authors：

LEI Kaijian ¹ , YU Lili ² , LI Zikang ³ ,  CHEN Xinzu ^1,3,4,5 , SIGES Research Group ⁵

1. Yibin Cancer Prevention and Control Center, the Second People’s Hospital of Yibin (West China Yibin Hospital, Sichuan University), Yibin, Sichuan 644000, P. R. China;
2. Yibin Center for Disease Control and Prevention, Yibin, Sichuan 644000, P. R. China;
3. Ya’an Cancer Prevention and Control Center, Ya’an People’s Hospital (West China Ya’an Hospital, Sichuan University), Ya’an, Sichuan 625000, P. R. China;
4. Ya’an Key Laboratory for High Altitude Medicine, Ya’an People’s Hospital (West China Ya’an Hospital, Sichuan University), Ya’an, Sichuan 625000, P. R. China;
5. Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

CHEN Xinzu, Email: chenxinzu@scu.edu.cn

Keywords：

Healthy China 2030; high-quality development; cancer prevention and control; public health; clinical epidemiology

DOI：

10.7507/1002-0179.202407307

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Cancer prevention and control is an important healthcare task towards major diseases of the Chinese people and an important part of the “Healthy China 2030” plan outline. This article summarizes and introduces the current status and practical experience of subnational cancer prevention and treatment status in Yibin City and Ya’an City of Sichuan Province. Lung cancer, digestive system cancers, and cervical and breast cancers compose of the majority of cancers with high incidence. In the aspect of cancer epidemiology, there are certain disparities among cities and between urban and rural areas, among which the mortality risk of cancer in rural areas is higher. In Yibin and Ya’an cities, the specialized agencies and governance system for subnational cancer prevention and control are still in the early stage of development, and the background data such as cancer-specific survival rate, public awareness of core knowledge on cancer prevention and control, quality control of key techniques, and healthcare resources in subnational areas are still unclear. Therefore, all levels of cancer prevention and control need further strengthening the organizational leadership and system construction, and promoting the hierarchic healthcare and balanced development.

Citation： LEI Kaijian, YU Lili, LI Zikang, CHEN Xinzu, SIGES Research Group. High-quality development of subnational cancer prevention and control: investigation and experiences. West China Medical Journal, 2024, 39(12): 1948-1952. doi: 10.7507/1002-0179.202407307 Copy

1.	魏文强, 沈洪兵. 中国癌症防控历史、现状与展望. 中华疾病控制杂志, 2019, 23(10): 1165-1168, 1180.
2.	李茁钰, 刘凯, 张维汉, 等. 全球及中国胃癌的流行病学特点及趋势:2018–2022《全球癌症统计报告》解读. 中国普外基础与临床杂志, 2024, 31(10): 1236-1245.
3.	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
4.	Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(7): 783-791.
5.	曹巍, 胡莹云, 陈万青. 高质量推进癌症综合防治,有效降低癌症疾病负担. 中国肿瘤, 2024, 33(1): 1-5.
6.	新华社. 中共中央国务院印发《“健康中国 2030”规划纲要》. 中华人民共和国国务院公报, 2016(32): 5-20.
7.	Zou JC, Yang Y, Chen XZ, et al. Active eradication of helicobacter pylori within organized massive screening might improve survival of gastric cancer patients. Gastroenterology, 2023, 164(1): 162-163.
8.	中华人民共和国国家卫生健康委员会医疗应急司. 健康中国行动——癌症防治行动实施方案(2023-2030 年). 中国肿瘤, 2023, 32(12): 887-890.
9.	Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health, 2023, 8(12): e943-e955.
10.	陈心足, 胡建昆, SIGES 研究组. 胃癌防控策略的探索与优化:流行病学、病原微生物及危险因素. 中国普外基础与临床杂志, 2023, 30(1): 86-90.
11.	Yang K, Choi YY, Zhang WH, et al. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget, 2016, 7(28): 44660-44675.
12.	Zou JC, Wen MY, Huang Y, et al. Helicobacter pylori infection prevalence declined among an urban health check-up population in Chengdu, China: a longitudinal analysis of multiple cross-sectional studies. Front Public Health, 2023, 11: 1128765.
13.	Bai D, Liu K, Wang R, et al. Prevalence difference of helicobacter pylori infection between Tibetan and Han ethnics in China: a meta-analysis on epidemiologic studies (SIGES). Asia Pac J Public Health, 2023, 35(2-3): 103-111.
14.	Chen XZ, Hu JK, Zhou ZG. Importance of organized screening and surveillance for colorectal cancer in China: epidemiological differences from Europe. Eur J Cancer Prev, 2015, 24(6): 459-460.
15.	Gou HF, Liu Y, Yang TX, et al. Necessity of organized low-dose computed tomography screening for lung cancer: from epidemiologic comparisons between China and the Western nations. Oncotarget, 2017, 8(1): 1788-1795.
16.	陈萍, 傅晓花, 薛康, 等. 四川高海拔藏族居民癌症防治知识知晓率及参与筛查情况分析. 现代肿瘤医学, 2024, 32(9): 1709-1716.
17.	马婧, 乔良, 钟志刚, 等. 基于倾向性评分匹配的四川省居民癌症防治核心知识知晓情况变化分析. 肿瘤预防与治疗, 2024, 37(2): 140-148.
18.	Wang R, Bai D, Xiang W, et al. Tibetan ethnicity, birthplace, helicobacter pylori infection, and gastric cancer risk. Am J Gastroenterol, 2022, 117(6): 1010.
19.	Yu TH, Wang R, Chen XZ, et al. Multifactorial co-exposure within family of gastric cancer: increased risk of familial gastric cancer and tailored prevention. Med Oncol, 2022, 40(1): 19.
20.	崔娟, 赵一凡, 范雷, 等. 乡村医生癌症防治知识干预效果评价. 中国公共卫生管理, 2015, 31(4): 513-514.
21.	四川省卫生健康委员会. 全力推进“健康四川”行动,探索建立“四川癌防模式”. 健康中国观察, 2023(12): 24-26.
22.	Chen XC, Chen XZ. Epidemiological differences in haematological malignancies between Europe and China. Lancet Oncol, 2014, 15(11): e471-472.
23.	王淼, 石柯灿, 陈蕾, 等. 四川大学华西医院领办型紧密医疗联合体特征分析. 华西医学, 2019, 34(12): 1422-1425.
24.	陈心足, 罗英, 夏一尹, 等. 宜宾市“省-市-县-乡”四级分级诊疗体系建设的初步探索. 华西医学, 2021, 36(7): 949-953.
25.	董家鸿, 张宗久. 中国整合式卫生医护体系发展报告(2023). 北京: 社会科学文献出版社, 2024: 1.
26.	中华人民共和国国家卫生健康委员会. 关于印发“十四五”全民健康信息化规划的通知. 中华人民共和国国家卫生健康委员会公报, 2022(11): 7-18.
27.	《中国卫生信息管理杂志》编委会. 以人民健康为中心推动“十四五”全民健康信息化规划落地实施. 中国卫生信息管理杂志, 2023, 20(1): 5.
28.	陈嘉莉, 马自强, 兰亚杰, 等. 基于区块链技术的医疗信息共享研究综述. 计算机应用研究, 2024, 41(9): 2573-2584.
29.	俞思伟, 傅马, 冯露漪, 等. 卫生健康领域区块链应用现状研究与趋势分析. 中国数字医学, 2024, 19(1): 1-6.
30.	朱春伦, 唐玲, 邵维君, 等. 基于区块链的异地医疗信息共享试点项目实践. 中国数字医学, 2024, 19(1): 29-33.

1. 魏文强, 沈洪兵. 中国癌症防控历史、现状与展望. 中华疾病控制杂志, 2019, 23(10): 1165-1168, 1180.
2. 李茁钰, 刘凯, 张维汉, 等. 全球及中国胃癌的流行病学特点及趋势:2018–2022《全球癌症统计报告》解读. 中国普外基础与临床杂志, 2024, 31(10): 1236-1245.
3. Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
4. Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(7): 783-791.
5. 曹巍, 胡莹云, 陈万青. 高质量推进癌症综合防治,有效降低癌症疾病负担. 中国肿瘤, 2024, 33(1): 1-5.
6. 新华社. 中共中央国务院印发《“健康中国 2030”规划纲要》. 中华人民共和国国务院公报, 2016(32): 5-20.
7. Zou JC, Yang Y, Chen XZ, et al. Active eradication of helicobacter pylori within organized massive screening might improve survival of gastric cancer patients. Gastroenterology, 2023, 164(1): 162-163.
8. 中华人民共和国国家卫生健康委员会医疗应急司. 健康中国行动——癌症防治行动实施方案(2023-2030 年). 中国肿瘤, 2023, 32(12): 887-890.
9. Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health, 2023, 8(12): e943-e955.
10. 陈心足, 胡建昆, SIGES 研究组. 胃癌防控策略的探索与优化:流行病学、病原微生物及危险因素. 中国普外基础与临床杂志, 2023, 30(1): 86-90.
11. Yang K, Choi YY, Zhang WH, et al. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget, 2016, 7(28): 44660-44675.
12. Zou JC, Wen MY, Huang Y, et al. Helicobacter pylori infection prevalence declined among an urban health check-up population in Chengdu, China: a longitudinal analysis of multiple cross-sectional studies. Front Public Health, 2023, 11: 1128765.
13. Bai D, Liu K, Wang R, et al. Prevalence difference of helicobacter pylori infection between Tibetan and Han ethnics in China: a meta-analysis on epidemiologic studies (SIGES). Asia Pac J Public Health, 2023, 35(2-3): 103-111.
14. Chen XZ, Hu JK, Zhou ZG. Importance of organized screening and surveillance for colorectal cancer in China: epidemiological differences from Europe. Eur J Cancer Prev, 2015, 24(6): 459-460.
15. Gou HF, Liu Y, Yang TX, et al. Necessity of organized low-dose computed tomography screening for lung cancer: from epidemiologic comparisons between China and the Western nations. Oncotarget, 2017, 8(1): 1788-1795.
16. 陈萍, 傅晓花, 薛康, 等. 四川高海拔藏族居民癌症防治知识知晓率及参与筛查情况分析. 现代肿瘤医学, 2024, 32(9): 1709-1716.
17. 马婧, 乔良, 钟志刚, 等. 基于倾向性评分匹配的四川省居民癌症防治核心知识知晓情况变化分析. 肿瘤预防与治疗, 2024, 37(2): 140-148.
18. Wang R, Bai D, Xiang W, et al. Tibetan ethnicity, birthplace, helicobacter pylori infection, and gastric cancer risk. Am J Gastroenterol, 2022, 117(6): 1010.
19. Yu TH, Wang R, Chen XZ, et al. Multifactorial co-exposure within family of gastric cancer: increased risk of familial gastric cancer and tailored prevention. Med Oncol, 2022, 40(1): 19.
20. 崔娟, 赵一凡, 范雷, 等. 乡村医生癌症防治知识干预效果评价. 中国公共卫生管理, 2015, 31(4): 513-514.
21. 四川省卫生健康委员会. 全力推进“健康四川”行动,探索建立“四川癌防模式”. 健康中国观察, 2023(12): 24-26.
22. Chen XC, Chen XZ. Epidemiological differences in haematological malignancies between Europe and China. Lancet Oncol, 2014, 15(11): e471-472.
23. 王淼, 石柯灿, 陈蕾, 等. 四川大学华西医院领办型紧密医疗联合体特征分析. 华西医学, 2019, 34(12): 1422-1425.
24. 陈心足, 罗英, 夏一尹, 等. 宜宾市“省-市-县-乡”四级分级诊疗体系建设的初步探索. 华西医学, 2021, 36(7): 949-953.
25. 董家鸿, 张宗久. 中国整合式卫生医护体系发展报告(2023). 北京: 社会科学文献出版社, 2024: 1.
26. 中华人民共和国国家卫生健康委员会. 关于印发“十四五”全民健康信息化规划的通知. 中华人民共和国国家卫生健康委员会公报, 2022(11): 7-18.
27. 《中国卫生信息管理杂志》编委会. 以人民健康为中心推动“十四五”全民健康信息化规划落地实施. 中国卫生信息管理杂志, 2023, 20(1): 5.
28. 陈嘉莉, 马自强, 兰亚杰, 等. 基于区块链技术的医疗信息共享研究综述. 计算机应用研究, 2024, 41(9): 2573-2584.
29. 俞思伟, 傅马, 冯露漪, 等. 卫生健康领域区块链应用现状研究与趋势分析. 中国数字医学, 2024, 19(1): 1-6.
30. 朱春伦, 唐玲, 邵维君, 等. 基于区块链的异地医疗信息共享试点项目实践. 中国数字医学, 2024, 19(1): 29-33.

West China Medical Journal

High-quality development of subnational cancer prevention and control: investigation and experiences

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content